These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31423278)
41. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Kim MA; Lee HS; Lee HE; Kim JH; Yang HK; Kim WH Histopathology; 2009 Mar; 54(4):442-51. PubMed ID: 19309396 [TBL] [Abstract][Full Text] [Related]
42. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma. Meng FT; Huang M; Shao F; Huang Q Cancer Biomark; 2018; 23(3):353-361. PubMed ID: 30248044 [TBL] [Abstract][Full Text] [Related]
43. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691 [TBL] [Abstract][Full Text] [Related]
44. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097 [TBL] [Abstract][Full Text] [Related]
46. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. Gu MJ; Choi JH J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361 [TBL] [Abstract][Full Text] [Related]
47. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535 [TBL] [Abstract][Full Text] [Related]
48. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway. Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047 [TBL] [Abstract][Full Text] [Related]
49. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition. Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916 [TBL] [Abstract][Full Text] [Related]
50. Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. Zhou C; Zheng Y; Li L; Zhai W; Li R; Liang Z; Zhao L Oncol Rep; 2015 Aug; 34(2):610-6. PubMed ID: 26043778 [TBL] [Abstract][Full Text] [Related]
51. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337 [TBL] [Abstract][Full Text] [Related]
52. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma. Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721 [TBL] [Abstract][Full Text] [Related]
53. Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients. Xu J; Lv W; Hu Y; Wang L; Wang Y; Cao J; Hu J J Cancer; 2017; 8(13):2523-2531. PubMed ID: 28900490 [No Abstract] [Full Text] [Related]
54. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
55. HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Xia YY; Yin L; Tian H; Guo WJ; Jiang N; Jiang XS; Wu J; Chen M; Wu JZ; He X Onco Targets Ther; 2015; 8():169-76. PubMed ID: 25653540 [TBL] [Abstract][Full Text] [Related]
56. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer. Song IH; Kim KR; Lim S; Kim SH; Sung CO Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157 [TBL] [Abstract][Full Text] [Related]
58. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482 [TBL] [Abstract][Full Text] [Related]
59. Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis. Malgulwar PB; Nambirajan A; Pathak P; Rajeshwari M; Suri V; Sarkar C; Singh M; Sharma MC Hum Pathol; 2018 Dec; 82():149-157. PubMed ID: 30067950 [TBL] [Abstract][Full Text] [Related]
60. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Luo W; Fang W; Li S; Yao K Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]